Search Results - Ghade, Nikhil

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Comparative physicochemical and structural characterisation studies establish high biosimilarity between BGL-ASP and reference insulin aspart

    Comparative physicochemical and structural characterisation studies establish high biosimilarity between BGL-ASP and reference insulin aspart by Ghade, Nikhil S., Thappa, Damodar K., Lona, Jeseena, Krishnan, Archana R., Sonar, Sanjay M.

    Published in Scientific reports
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart

    In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart by Mishra, Akshay G., Deshmane, Rutuja B., Thappa, Damodar K., Lona, Jeseena, Ghade, Nikhil S., Sonar, Sanjay M., Krishnan, Archana R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid ® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study

    Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid ® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-... by Dongre, Sneha A, Kulkarni, Gauri A, Mishra, Akshay, Deshmane, Rutuja B, Sonar, Nameeta, Yashi, Kanica, Thapa, Damodar, Ghade, Nikhil, Kadoo, Sachin M, Krishnan, Archana R, Sonar, Sanjay M

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Efficacy, safety, and immunogenicity of recombinant insulin aspart in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study

    Efficacy, safety, and immunogenicity of recombinant insulin aspart in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study by Dongre, Sneha A, Kulkarni, Gauri A, Mishra, Akshay, Deshmane, Rutuja B, Sonar, Nameeta, Yashi, Kanica, Thapa, Damodar, Ghade, Nikhil, Kadoo, Sachin M, Krishnan, Archana R, Sonar, Sanjay M

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: